Jennifer Brady, MD
Payments from drug & device makers
What this record shows
This record is dominated by education: $20,000 of the $27,757 with a category attached, or 72.1%. Intuitive Surgical accounts for 97.5% of it on its own, with 15 other manufacturers making up the rest. Among surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 76 payments — averaging $365.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$27K
- Merck$147
- Davol Inc.$147
- Solventum Corporation$85
- AbbVie$56
- Checkpoint Surgical, Inc$42
- plus $230 from 10 others
What the payments were for
- Speaking & faculty fees$5002%
- Travel & lodging$4,03015%
- Food & beverage$3,17711%
- Education$20,00072%
- Gifts$510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 50 | $27,050 |
| Merck | 7 | $147 |
| Davol Inc. | 2 | $147 |
| Solventum Corporation | 3 | $85 |
| AbbVie | 2 | $56 |
| Checkpoint Surgical, Inc | 1 | $42 |
| Integra Lifesciences Corporation | 2 | $41 |
| Theratechnologies Inc. | 1 | $29 |
| Johnson & Johnson | 1 | $26 |
| Shionogi Inc | 1 | $22 |
| TELA Bio, Inc. | 1 | $22 |
| GSK | 1 | $22 |
| Inari Medical, Inc. | 1 | $21 |
| Mimedx Group, Inc. | 1 | $18 |
| Elucent Medical | 1 | $16 |
| Smith+Nephew | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$25,596
- DAVINCI XI$1,000
- Phasix Mesh$123
How this compares
$27,757 in reported general payments places this provider in the 90th percentile of 1,596 surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 11 | $212 |
| Oxycodone Hcl | 14 | $57 |
| Tamoxifen Citrate | 11 | $54 |
Paid to pharmacies, not to this prescriber.
Other surgery in Troy
- Cheguevara AfanehNew York$1.4M
- Flavio Malcher Martins de OliveiraNew York$695K
- Yuri NovitskyNew York$548K
- Rasa ZarnegarNew York$478K
- Tanuja DamaniNew York$459K
- Benjamin SadowitzSyracuse$419K
- Stephen GoldstoneNy$386K
- Rache SimmonsNew York$371K
- George DenotoManhasset$333K
- Marina KurianNew York$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.